Safety of Hesperidin, Diosmin, and Aspirin During Pregnancy
Low-dose aspirin (60-150 mg daily) is safe and recommended for pregnant women at high risk for preeclampsia starting from the second trimester, while hesperidin and diosmin have limited safety data but appear safe based on small studies in the third trimester only.
Aspirin in Pregnancy
Evidence-Based Recommendations
The U.S. Preventive Services Task Force recommends low-dose aspirin for women at increased risk for preeclampsia, with substantial net benefit and no greater than small harms 1. The American College of Chest Physicians similarly recommends low-dose aspirin throughout pregnancy starting from the second trimester for women at risk for pre-eclampsia 2.
Benefits vs. Risks
Low-dose aspirin provides:
- 24% reduction in preeclampsia risk
- 14% reduction in preterm birth
- 20% reduction in intrauterine growth restriction 1
Critical caveat: The FDA label warns against aspirin use during the last 3 months of pregnancy unless specifically directed by a physician, as it may cause problems in the unborn child or complications during delivery 3. However, this conflicts with guideline recommendations and reflects older labeling.
Bleeding Risk Considerations
Recent population-based data shows aspirin use is associated with:
- Increased intrapartum bleeding (adjusted OR 1.63)
- Increased postpartum hemorrhage (adjusted OR 1.23)
- Increased postpartum hematoma (adjusted OR 2.21)
- Possible increased neonatal intracranial hemorrhage (adjusted OR 9.66) 4
However, the USPSTF found adequate evidence that low-dose aspirin does NOT increase risk for placental abruption, postpartum hemorrhage, or fetal intracranial bleeding in their meta-analysis 1. This discrepancy reflects different study populations and methodologies.
Practical Algorithm for Aspirin Use
Initiate aspirin if patient has:
- High-risk factors: History of preeclampsia, chronic hypertension, type 1 or 2 diabetes, renal disease, autoimmune disease, or multifetal gestation
- Timing: Start after 12 weeks gestation, ideally before 16-20 weeks 5
- Dose: 81-150 mg daily
- Duration: Continue until 36 weeks gestation
Do not use aspirin if:
- Known hypersensitivity to aspirin
- Active bleeding disorder
- No identifiable risk factors for preeclampsia
Hesperidin and Diosmin in Pregnancy
Safety Profile
The FDA label for diosmin explicitly states it is NOT recommended in pregnant and lactating women 6. The label notes:
- Animal studies suggest no developmental abnormalities
- Only small numbers of pregnant women have consumed diosmin (up to 900 mg/day) in the third trimester and first 4 weeks postpartum with no observed effects on fetus or baby
- No specific studies have been performed in pregnant populations
Limited Clinical Evidence
One small open study (N=50) evaluated micronized diosmin 90% and hesperidin 10% for hemorrhoids during pregnancy, finding:
- Treatment was well accepted
- Did not affect pregnancy, fetal development, birth weight, or infant growth
- Used for median 8 weeks before delivery and 4 weeks after 7
Critical limitation: This is a single, small, open-label study without adequate power to detect rare adverse events.
Clinical Recommendation
For aspirin: Use low-dose aspirin (81-150 mg daily) in high-risk pregnant women starting at 12-20 weeks gestation through 36 weeks. The benefits for preeclampsia prevention substantially outweigh the small increased bleeding risks 1, 2.
For hesperidin and diosmin: Avoid use during pregnancy due to insufficient safety data and explicit FDA recommendation against use 6. The single small study is inadequate to establish safety, particularly in the first and second trimesters where no data exists.
Common Pitfall to Avoid
Do not assume that "natural" flavonoid supplements are automatically safe in pregnancy. The absence of evidence is not evidence of safety, and the FDA specifically recommends against diosmin use in pregnancy 6.